← Back to Patent Explorer
US5683710A Expired / Lapsed US ⏱️ 0.0 years remaining

Percutaneous absorption preparation

Assignee: Toa Eiyo Ltd
•
Filing: 1995-09-13
•
Granted: 1997-11-04
•
Expires: 2015-09-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A percutaneous absorption preparation for use in the administration of isosorbide dinitrate (ISDN) as a coronary vasodilator into the living body by percutaneous absorption, which has excellent adhesion to the skin and does not cause pain and damage to stratum corneum when peeled off, is disclosed. The pressure-sensitive adhesive layer comprises an acrylic copolymer prepared by copolymerization of a monomer mixture comprising a (meth)acrylic acid alkyl ester and a functional monomer as the essential components, a fatty acid ester having a specified number of carbon atoms, a monoglyceride having a specified number of carbon atoms, and ISDN, and the pressure-sensitive adhesive layer is crosslinked. Since its skin adhesive property is improved by the inclusion of the monoglyceride, release of ISDN is improved and the area of the preparation can be decreased.

Inventors

  • 👤 Hitoshi Akemi
  • 👤 Takateru Muraoka
  • 👤 Kazuhiro Higashio
  • 👤 Saburo Otsuka
  • 👤 Takashi Kinoshita

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 20:33
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/7061; A61K31/00; A61K31/33; A61K31/335; A61K31/34; A61P; A61P9/00; A61P9/08; A61P9/10

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 189 words
A percutaneous absorption preparation comprising a backing and a pressure-sensitive adhesive layer containing a drug for percutaneous absorption formed on one side of the backing, wherein the pressure-sensitive adhesive layer comprises an acrylic copolymer prepared by copolymerization of a monomer mixture comprising a (meth)acrylic acid alkyl ester and a functional monomer as the essential components, a fatty acid ester comprising a higher fatty acid having 12 to 16 carbon atoms and a lower monohydric alcohol having 1 to 4 carbon atoms, a monoglyceride comprising a higher fatty acid having 8 to 10 carbon atoms and glycerol, wherein the weight ratio of said fatty acid ester to said monoglyceride is from 1:0.05 to 1:0.25, wherein the higher fatty acid is selected from the group consisting of caprylic acid, pelargonic acid and capric acid, and isosorbide dinitrate as the drug for percutaneous absorption, in an amount in the range of 2 to 50% by weight, and wherein the pressure-sensitive adhesive layer is crosslinked, wherein the total content of said fatty acid ester and monoglyceride is from 60 to 200 parts by weight per 100 parts by weight of said acrylic copolymer.
Claim 2
Dependent Claim 189 words
A percutaneous absorption preparation comprising a backing and a pressure-sensitive adhesive layer containing a drug for percutaneous absorption formed on one side of the backing, wherein the pressure-sensitive adhesive layer comprises an acrylic copolymer prepared by copolymerization of a monomer mixture comprising a (meth)acrylic acid alkyl ester and a functional monomer as the essential components, a fatty acid ester comprising a higher fatty acid having 12 to 16 carbon atoms and a lower monohydric alcohol having 1 to 4 carbon atoms, a monoglyceride comprising a higher fatty acid having 8 to 10 carbon atoms and glycerol, wherein the weight ratio of said fatty acid ester to said monoglyceride is from 1:0.05 to 1:0.25, wherein the higher fatty acid is selected from the group consisting of caprylic acid, pelargonic acid and capric acid, and isosorbide dinitrate as the drug for percutaneous absorption, in an amount in the range of 2 to 50% by weight, and wherein the pressure-sensitive adhesive layer is crosslinked, wherein the total content of said fatty acid ester and monoglyceride is from 60 to 200 parts by weight per 100 parts by weight of said acrylic copolymer.
Claim 3
Dependent Claim 40 words
The percutaneous absorption preparation as claimed in claim 1, wherein said backing is a porous film or a laminate of a porous film and a non-porous plastic film, and the pressure-sensitive adhesive layer is formed on the porous film side.
Claim 4
Dependent Claim 24 words
The percutaneous absorption preparation of claim 1, wherein the isosorbide dinitrate is in an amount in the range of 10 to 40% by weight.
Claim 5
Dependent Claim 26 words
The percutaneous absorption preparation of claim 1, wherein the total content of the fatty acid ester and monoglyceride is from 70 to 180 parts by weight.

References Cited (Backward Citations)

EP0062682A1 Cited
JPS57116011A Cited
WO1986006281A1 Cited
DE3839410A1 Cited
EP0436203A2 Cited
JPH03223212A Cited
US5204109A Cited
EP0531938A1 Cited
US5419912A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-11-03 2001-05-05 2001-11-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-11-03 2005-05-05 2005-11-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-11-03 2009-05-05 2009-11-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag